Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight

View source ↗

Summary

A clinical trial evaluating the effects of GLP-1 and GIP/GLP-1 analogs on dietary, metabolic, and behavioral parameters in people with excess body weight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 and GIP/GLP-1 analogs

Snippet

Sponsor: Medical University of Warsaw | Conditions: GLP-1, Nutrition | Status: RECRUITING